These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12562345)

  • 1. Clinical trial of bleaching treatment with 10% all-trans retinol gel.
    Yoshimura K; Momosawa A; Aiba E; Sato K; Matsumoto D; Mitoma Y; Harii K; Aoyama T; Iga T
    Dermatol Surg; 2003 Feb; 29(2):155-60; discussion 160. PubMed ID: 12562345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of topical bleaching treatment with nanoscale tretinoin particles and hydroquinone for hyperpigmented skin lesions.
    Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Machino C; Suga H; Watanabe-Ono A; Inoue K; Gonda K; Yoshimura K
    Dermatol Surg; 2007 Aug; 33(8):937-44. PubMed ID: 17661936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel.
    Yoshimura K; Harii K; Aoyama T; Shibuya F; Iga T
    Aesthetic Plast Surg; 1999; 23(4):285-91. PubMed ID: 10441721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone.
    Yoshimura K; Momosawa A; Watanabe A; Sato K; Matsumoto D; Aiba E; Harii K; Yamamoto T; Aoyama T; Iga T
    Dermatol Surg; 2002 Dec; 28(12):1153-7; discussion 1158. PubMed ID: 12472496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment.
    Yoshimura K; Harii K; Masuda Y; Takahashi M; Aoyama T; Iga T
    Aesthetic Plast Surg; 2001; 25(2):129-33. PubMed ID: 11349303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals.
    Yoshimura K; Harii K; Aoyama T; Iga T
    Plast Reconstr Surg; 2000 Mar; 105(3):1097-108; discussion 1109-10. PubMed ID: 10724272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
    Draelos ZD
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians.
    Momosawa A; Kurita M; Ozaki M; Miyamoto S; Kobayashi Y; Ban I; Harii K
    Plast Reconstr Surg; 2008 Jan; 121(1):282-288. PubMed ID: 18176232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
    Cook-Bolden FE; Hamilton SF
    Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis.
    Iida S; Takushima A; Ohura N; Sato S; Kurita M; Harii K
    Dermatol Surg; 2013 Aug; 39(8):1237-42. PubMed ID: 23577722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for acquired dermal melanocytosis.
    Momosawa A; Yoshimura K; Uchida G; Sato K; Aiba E; Matsumoto D; Yamaoka H; Mihara S; Tsukamoto K; Harii K; Aoyama T; Iga T
    Dermatol Surg; 2003 Oct; 29(10):1001-7. PubMed ID: 12974695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women With Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin.
    Herndon JH; Jiang LI; Kononov T; Fox T
    J Drugs Dermatol; 2016 Apr; 15(4):476-82. PubMed ID: 27050703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
    Grimes PE
    Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hydroquinone formulation with increased stability and decreased potential for irritation.
    Smiles KA; Dong KK; Canning MT; Grimson R; Walfield AM; Yarosh DB
    J Cosmet Dermatol; 2007 Jun; 6(2):83-8. PubMed ID: 17524123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians.
    Kurita M; Kato H; Yoshimura K
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):955-63. PubMed ID: 18456589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients.
    Bulengo-Ransby SM; Griffiths CE; Kimbrough-Green CK; Finkel LJ; Hamilton TA; Ellis CN; Voorhees JJ
    N Engl J Med; 1993 May; 328(20):1438-43. PubMed ID: 8479462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation.
    Kang S; Duell EA; Fisher GJ; Datta SC; Wang ZQ; Reddy AP; Tavakkol A; Yi JY; Griffiths CE; Elder JT
    J Invest Dermatol; 1995 Oct; 105(4):549-56. PubMed ID: 7561157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.